COMPARED WITH PLACEBO in Croatian translation

• u usporedbi s placebom
• uspoređen s placebom
• u odnosu na placebo
• uspoređivan s placebom
• su primali placebo
• u usporedbi s onima koji su primali placebo

Examples of using Compared with placebo in English and their translations into Croatian

Resolor 2 mg once a day was also compared with placebo in another main study involving 374 men with chronic constipation.
Uzimanje 2 mg lijeka Resolor jedanput dnevno također je u drugom ispitivanju s 374 muškarca s kroničnom konstipacijom uspoređeno s placebom.

The percentage of patients achieving PASI 75 was significantly greater for Taltz compared with placebo and etanercept as early as Week 1.
Postotak bolesnika koji su ostvarili rezultat PASI 75 bio je značajno veći u skupini koja je primala Taltz nego u onima koje su primale placebo i etanercept, i to već od tjedna.

When compared with placebo, the success rate was 67% for Apoquel-treated dogs and 29% for placebo-treated dogs.
U usporedbi s placebom, stopa uspješnosti iznosila je 67% u slučaju pasa liječenih lijekom Apoquel i 29% u slučaju pasa liječenih placebom..

120 mg promoted significant weight loss compared with placebo 3.85 kg
120 mg promicali su značajan gubitak težine u usporedbi s placebom 3.85 kg

Percent improvement in Bath Ankylosing Spondylitis Disease Activity Index(BASDAI) scores compared with placebo at week 24.
Bath Ankylosing Spondylitis Disease Activity Indeks u usporedbi s placebo skupinom u 24. tjednu.

Compared with placebo, ZOSTAVAX induced a higher VZV-specific immune response at 6 weeks postvaccination.
U usporedbi s placebom, ZOSTAVAX je izazvao viši specifični imunološki odgovor protiv virusa varicella-zoster 6 tjedana nakon cijepljenja.

Ameluz was also compared with placebo treatment in a randomised,
Ameluz je također uspoređen s placebo liječenjem u randomiziranom,

EVISTA reduced the incidence of clinical vertebral fractures by 35% compared with placebo HR 0.65,
U usporedbi s placebom Evista je smanjila incidenciju kliničkih prijeloma kralježaka za 35% HR 0,65;

CHAMPIX also significantly reduced reinforcing effects of smoking that can perpetuate smoking behaviour in patients who smoke during treatment compared with placebo.
CHAMPIX je u usporedbi s placebom također značajno umanjio učinke koji potiču na pušenje i koji bi mogli održati pušačko ponašanje u onih bolesnika koji puše tijekom liječenja.

Compared with placebo, these medicines provide a small improvement in lung function measurements
Rezultati istraživanja U usporedbi s placebom ti lijekovi omogućuju malo poboljšanje funkcije pluća

Fondaparinux provided a significant reduction in the overall rate of VTE compared with placebo 3 patients(1.4%) vs 77 patients(35%).
Fondaparinuks je omogućio značajno smanjenje ukupnog broja VTE u usporedbi s placebom 3 bolesnika(1,4%) prema 77 bolesnika 35.

waist circumference compared with placebo(tables 3, 4 and 5).
opseg struka u usporedbi s placebom(tablice 3, 4 i 5).

Improvement in EET compared with placebo was seen at Day 2
Poboljšanje EET vrijednosti u usporedbi s placebom primijećeno je 2. dana,

Albiglutide slowed gastric emptying compared with placebo for both solids and liquids when 100 mg was administered as a single dose in healthy subjects see section 5.1.
U zdravih ispitanika koji su primili jednokratnu dozu od 100 mg, albiglutid je usporio pražnjenje želuca u usporedbi s placebom i kod krute hrane i kod tekućina vidjeti dio 5.1.

Pioglitazone did not cause statistically significant increases in LDL cholesterol levels compared with placebo, whilst reductions were observed with metformin and gliclazide.
Pioglitazon nije uzrokovao statistički značajna povišenja razine LDL-kolesterola u usporedbi s placebom, dok su smanjenja opažena uz metformin i gliklazid.

Reduction in LDL-C from baseline at week 52 compared with placebo was consistent across background lipid-lowering therapies optimised for LDL-C and cardiovascular risk.
Smanjenje LDL-C-a u 52. tjednu u odnosu na početne vrijednosti, u usporedbi s placebom, bilo je dosljedno pri svim osnovnim terapijama za snižavanje lipida koje su optimizirane za LDL-C i kardiovaskularni rizik.

There was also a 38% reduction in the risk of developing an SRE for ibandronic acid treated patients when compared with placebo relative risk 0.62, p=0.003.
U usporedbi s placebo grupom, u bolesnika liječenih ibandronatnom kiselinom rizik od razvoja SRE bio je za 38% manji relativni rizik 0,62; p=0, 003.

Stivarga was compared with placebo(a dummy treatment) and the main measure of.
lijek Stivarga uspoređen je s placebom prividno.

A statistically significant improvement compared with placebo in the TDI focal score at Week 24 was demonstrated for Incruse(1.0 units, p< 0.001) in the 24-week study.
U 24-tjednom ispitivanju Incruse je doveo do statistički značajnog poboljšanja ukupnog TDI rezultata nakon 24 tjedna u usporedbi s placebom 1, 0 bod; p< 0, 001.

0.001) higher pain intensity difference at 10 minutes(PID10) compared with placebo.
višu razliku intenziteta boli nakon 10 minuta(RIB10) u usporedbi s placebom.